Wegovy vs Mounjaro: Key Differences Explained for UK Buyers
Is Wegovy the Same as Mounjaro? Understanding the Core Differences
When comparing whether Wegovy is the same as Mounjaro, the fundamental difference lies in their active ingredients and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single natural hormone involved in appetite regulation. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors, making it a dual-action treatment. Both are prescription-only medicines that require clinical assessment and are designed to be used alongside a reduced-calorie diet and increased physical activity.
At EverydayMeds, we provide access to both treatments through our comprehensive online consultation process. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine medications with proper cold-chain handling. The choice between Wegovy and Mounjaro often comes down to individual patient factors, previous treatment responses, and prescriber recommendations based on your medical history and weight management goals.
Wegovy vs Mounjaro Pricing: UK Online Comparison and Value
Understanding the cost difference between Wegovy and Mounjaro is crucial when determining which treatment represents better value for your circumstances. Wegovy starts from £79.99 for the 0.25mg starter dose, with our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) available for £169.99. The maintenance dose of 2.4mg costs £209.99, or you can secure three months' supply with our Ultimate Stability Trio for £649.99. New customers benefit from code FIRST40, whilst returning customers use DOSE25 at checkout.
When considering whether Wegovy is the same as Mounjaro in terms of cost-effectiveness, it's important to factor in the complete treatment journey. Wegovy follows a structured dose escalation over 16 weeks before reaching maintenance, whilst Mounjaro has a different titration schedule. Both require ongoing commitment for sustained results, as clinical evidence shows weight regain occurs when treatment stops. Our bundle options provide convenience and Reliable Supply continuity, reducing the need for frequent reordering during your weight management journey.
Clinical Evidence: How Wegovy Compares to Mounjaro in Studies
The question of whether Wegovy is the same as Mounjaro extends to their clinical trial evidence, though direct head-to-head comparisons are limited. Wegovy demonstrated significant efficacy in the STEP clinical programme, with patients achieving an average of approximately clinically studied weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). The STEP trials enrolled diverse populations and showed consistent benefits across different patient groups.
Mounjaro's SURMOUNT trials similarly demonstrated substantial weight loss, though comparing trial results directly isn't appropriate due to different study designs, populations, and endpoints. Both treatments have shown cardiovascular benefits in dedicated outcome studies, with Wegovy's SELECT trial demonstrating a 20% reduction in major cardiovascular events. Your prescriber can review the specific evidence most relevant to your individual circumstances when determining which treatment may be more suitable.
How Wegovy Works: Understanding the GLP-1 Mechanism
To understand whether Wegovy is the same as Mounjaro, it's essential to grasp how Wegovy functions in the body. Wegovy contains semaglutide, which mimics the action of GLP-1 (glucagon-like peptide-1), a natural hormone released when we eat. This hormone signals to the brain's appetite centres that we're full, promoting satiety and reducing the desire to eat. The medication slows gastric emptying, meaning food stays in the stomach longer, contributing to prolonged feelings of fullness. Wegovy also influences areas of the brain involved in food reward and craving, potentially reducing the appeal of high-calorie foods. The once-weekly injection maintains steady medication levels, providing consistent appetite regulation throughout the week.
Ordering Process: Getting Wegovy vs Mounjaro Through EverydayMeds
The process for obtaining either treatment remains consistent, whether you're wondering if Wegovy is the same as Mounjaro or have already decided on your preferred option. Begin with our 3-minute online clinical assessment, which covers your medical history, current medications, and weight management goals. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring the chosen treatment is appropriate for your circumstances. Once approved, your genuine medication is dispatched via next-day delivery in temperature-controlled packaging. All Wegovy pens are sourced directly from Novo Nordisk, maintaining the cold-chain integrity essential for medication stability. We include comprehensive injection guidance and ongoing support throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro Advantages
A practical difference when considering whether Wegovy is the same as Mounjaro relates to storage requirements and convenience factors. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but once removed, they remain stable at room temperature for up to 6 weeks, provided temperatures don't exceed 30°C. This storage advantage over Mounjaro (which allows only 21 days at room temperature) makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules. The Wegovy FlexTouch pen design is user-friendly, with clear dose markings and an audible click confirmation. Dose escalation follows a structured 16-week schedule, starting at 0.25mg weekly and increasing gradually to the 2.4mg maintenance dose, allowing your body to adjust and minimising potential side effects.
Wegovy vs Mounjaro: Which Treatment Suits UK Patients Best?
Determining whether Wegovy is the same as Mounjaro for your specific situation involves considering multiple patient-specific factors beyond just the mechanism of action. Wegovy may be particularly suitable for patients who prioritise treatment convenience, given its superior room temperature storage capability and well-established dose escalation protocol. The extensive STEP trial programme provides robust long-term safety data, whilst the once-weekly injection schedule fits easily into most lifestyles.
Some patients prefer Wegovy's single-target approach, particularly if they've previously responded well to GLP-1 treatments or have specific contraindications to dual-receptor agonists. The cardiovascular benefits demonstrated in the SELECT trial may make Wegovy particularly relevant for patients with existing cardiovascular risk factors. However, the choice ultimately depends on individual medical history, treatment goals, and prescriber assessment of which option offers the best risk-benefit profile for your circumstances.
Start Your Weight Management Journey: Expert Prescription Support
Understanding whether Wegovy is the same as Mounjaro is just the first step towards effective weight management support. At EverydayMeds, our experienced prescribers evaluate your complete medical picture to recommend the most appropriate treatment option. Both medications represent significant advances in obesity medicine, offering genuine hope for sustained weight loss when used as part of a comprehensive lifestyle approach. Remember to apply discount code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing from £79.99. Your order includes full prescriber consultation, genuine Novo Nordisk medication, and ongoing clinical support. Take the first step towards your weight management goals by completing our secure online assessment today at https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
